Search research articles
Contact Us
Filters
Showing results (51-60 of 75) with videos related to
Page
of 8
Sort By:
Leukemia Research
|
September 29, 2017
Randomized phase II trial of cytosine arabinoside with and without the CHK1 inhibitor MK-8776 in relapsed and refractory acute myeloid leukemia
Jonathan A Webster, Raoul Tibes, Larry Morris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 21, 2015
Genome-Wide Analysis Uncovers Novel Recurrent Alterations in Primary Central Nervous System Lymphomas
Esteban Braggio, Scott Van Wier, Juhi Ojha, et al.
The Lancet. Oncology
|
August 23, 2015
Safety and tolerability of guadecitabine (SGI-110) in patients with myelodysplastic syndrome and acute myeloid leukaemia: a multicentre, randomised, dose-escalation phase 1 study
Jean-Pierre J Issa, Gail Roboz, David Rizzieri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 12, 2013
Phase I study of the Hedgehog pathway inhibitor IPI-926 in adult patients with solid tumors
Antonio Jimeno, Glen J Weiss, Wilson H Miller, et al.
Leukemia Research
|
May 15, 2012
Allogeneic stem cell transplantation for myeloproliferative neoplasm in blast phase
Chad Cherington, James L Slack, Jose Leis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 8, 2016
Phase I Study Evaluating WEE1 Inhibitor AZD1775 As Monotherapy and in Combination With Gemcitabine, Cisplatin, or Carboplatin in Patients With Advanced Solid Tumors
Suzanne Leijen, Robin M J M van Geel, Anna C Pavlick, et al.
Haematologica
|
September 6, 2015
An International MDS/MPN Working Group's perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic/myeloproliferative neoplasms
Tariq I Mughal, Nicholas C P Cross, Eric Padron, et al.
Cancer Discovery
|
April 24, 2023
Mitophagy Promotes Resistance to BH3 Mimetics in Acute Myeloid Leukemia
Christina Glytsou, Xufeng Chen, Emmanouil Zacharioudakis, et al.
Plos One
|
July 17, 2015
A Multidisciplinary Biospecimen Bank of Renal Cell Carcinomas Compatible with Discovery Platforms at Mayo Clinic, Scottsdale, Arizona
Thai H Ho, Rafael Nunez Nateras, Huihuang Yan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 9, 2012
A multicenter, phase I, dose-escalation study to assess the safety, tolerability, and pharmacokinetics of etirinotecan pegol in patients with refractory solid tumors
Gayle S Jameson, John T Hamm, Glen J Weiss, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 75) with videos related to
Sort By:
Page
of 8
Leukemia Research
|
September 29, 2017
Randomized phase II trial of cytosine arabinoside with and without the CHK1 inhibitor MK-8776 in relapsed and refractory acute myeloid leukemia
Jonathan A Webster, Raoul Tibes, Larry Morris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 21, 2015
Genome-Wide Analysis Uncovers Novel Recurrent Alterations in Primary Central Nervous System Lymphomas
Esteban Braggio, Scott Van Wier, Juhi Ojha, et al.
The Lancet. Oncology
|
August 23, 2015
Safety and tolerability of guadecitabine (SGI-110) in patients with myelodysplastic syndrome and acute myeloid leukaemia: a multicentre, randomised, dose-escalation phase 1 study
Jean-Pierre J Issa, Gail Roboz, David Rizzieri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 12, 2013
Phase I study of the Hedgehog pathway inhibitor IPI-926 in adult patients with solid tumors
Antonio Jimeno, Glen J Weiss, Wilson H Miller, et al.
Leukemia Research
|
May 15, 2012
Allogeneic stem cell transplantation for myeloproliferative neoplasm in blast phase
Chad Cherington, James L Slack, Jose Leis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 8, 2016
Phase I Study Evaluating WEE1 Inhibitor AZD1775 As Monotherapy and in Combination With Gemcitabine, Cisplatin, or Carboplatin in Patients With Advanced Solid Tumors
Suzanne Leijen, Robin M J M van Geel, Anna C Pavlick, et al.
Haematologica
|
September 6, 2015
An International MDS/MPN Working Group's perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic/myeloproliferative neoplasms
Tariq I Mughal, Nicholas C P Cross, Eric Padron, et al.
Cancer Discovery
|
April 24, 2023
Mitophagy Promotes Resistance to BH3 Mimetics in Acute Myeloid Leukemia
Christina Glytsou, Xufeng Chen, Emmanouil Zacharioudakis, et al.
Plos One
|
July 17, 2015
A Multidisciplinary Biospecimen Bank of Renal Cell Carcinomas Compatible with Discovery Platforms at Mayo Clinic, Scottsdale, Arizona
Thai H Ho, Rafael Nunez Nateras, Huihuang Yan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 9, 2012
A multicenter, phase I, dose-escalation study to assess the safety, tolerability, and pharmacokinetics of etirinotecan pegol in patients with refractory solid tumors
Gayle S Jameson, John T Hamm, Glen J Weiss, et al.
Page
of 8